Search

everythinglearnresearchcommunity

for

Search:↓

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Women with PCOS have higher risks of heart disease, type 2 diabetes, and endometrial cancer.

Ovarian drilling surgery is not clearly better than medical treatments for PCOS symptoms.

PCOS increases sexual pain and distress in infertile Iranian women.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Polycystic ovary syndrome and iron overload share similar symptoms and can be potentially treated with blood removal, diet changes, and probiotics.

Hirsutism in GCC countries is influenced by genetics, obesity, and lifestyle, with cultural stigma delaying treatment, highlighting the need for tailored health strategies.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Increasing light exposure in winter can make mares ovulate and cycle earlier.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Combining a GnRH agonist with a low-dose oral contraceptive is more effective and safer for treating hirsutism than using either alone.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

GnRH treatment can reduce breast cancer cell invasion.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

Removing both ovaries treated the woman's excess male hormone symptoms.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

Goserelin injections can effectively manage hyperandrogenism symptoms in postmenopausal women who can't have surgery.

Ovarian hyperthecosis should be considered in young women with severe male-like symptoms and can be managed with hormone treatments.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.